T. Rowe Price Associates’s Howard Bancorp, Inc. Common Stock HBMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-25,851
Closed -$563K 3071
2021
Q4
$563K Sell
25,851
-238
-0.9% -$5.09K ﹤0.01% 2332
2021
Q3
$529K Sell
26,089
-2,497,934
-99% -$47.8M ﹤0.01% 2362
2021
Q2
$40.7M Buy
2,524,023
+19,025
+0.8% +$314K ﹤0.01% 1104
2021
Q1
$41.2M Sell
2,504,998
-9,320
-0.4% -$133K ﹤0.01% 1070
2020
Q4
$29.7M Buy
2,514,318
+104,994
+4% +$1.18M ﹤0.01% 1117
2020
Q3
$21.6M Buy
2,409,324
+539,291
+29% +$5.24M ﹤0.01% 1139
2020
Q2
$19.9M Buy
1,870,033
+128,213
+7% +$1.31M ﹤0.01% 1149
2020
Q1
$18.9M Buy
1,741,820
+56,329
+3% +$878K ﹤0.01% 1093
2019
Q4
$28.5M Buy
1,685,491
+2,724
+0.2% +$45.3K ﹤0.01% 1078
2019
Q3
$28.1M Buy
1,682,767
+119,100
+8% +$1.8M ﹤0.01% 1045
2019
Q2
$23.7M Sell
1,563,667
-14,143
-0.9% -$201K ﹤0.01% 1134
2019
Q1
$23.4M Sell
1,577,810
-23,188
-1% -$326K ﹤0.01% 1130
2018
Q4
$22.9M Buy
1,600,998
+75,853
+5% +$1.16M ﹤0.01% 1101
2018
Q3
$27M Sell
1,525,145
-21,903
-1% -$382K ﹤0.01% 1121
2018
Q2
$27.8M Sell
1,547,048
-10,287
-0.7% -$190K ﹤0.01% 1085
2018
Q1
$30.8M Buy
1,557,335
+176,799
+13% +$3.57M ﹤0.01% 1037
2017
Q4
$30.4M Buy
1,380,536
+155,828
+13% +$3.33M ﹤0.01% 1049
2017
Q3
$25.6M Buy
1,224,708
+168,440
+16% +$3.29M ﹤0.01% 1095
2017
Q2
$20.3M Buy
1,056,268
+40,985
+4% +$773K ﹤0.01% 1167
2017
Q1
$19M Buy
1,015,283
+330,556
+48% +$5.77M ﹤0.01% 1185
2016
Q4
$10.3M Buy
684,727
+89,410
+15% +$1.26M ﹤0.01% 1308
2016
Q3
$7.86M Hold
595,317
﹤0.01% 1360
2016
Q2
$7.74M Buy
595,317
+7,961
+1% +$100K ﹤0.01% 1330
2016
Q1
$7.07M Buy
587,356
+9,046
+2% +$112K ﹤0.01% 1334
2015
Q4
$7.64M Sell
578,310
-2,550
-0.4% -$34.4K ﹤0.01% 1337
2015
Q3
$8.25M Buy
580,860
+600
+0.1% +$8.41K ﹤0.01% 1347
2015
Q2
$7.78M Buy
+580,260
New +$8M ﹤0.01% 1402

T. Rowe Price Associates's HBMD Position: Q1 2022 in Review

T. Rowe Price Associates sold out of Howard Bancorp, Inc. Common Stock (HBMD) in Q1 2022, closing a stake of 25,851 shares — an estimated $563K sold.

T. Rowe Price Associates first reported a position in HBMD in Q2 2015 and held it in 27 quarters. The position peaked at $41.2M in Q1 2021. 0 funds tracked by Wall St. Rank hold HBMD as of Q1 2022.

  • T. Rowe Price Associates reported no remaining Howard Bancorp, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • T. Rowe Price Associates sold 25,851 Howard Bancorp, Inc. Common Stock shares in Q1 2022, an estimated $563K.
  • T. Rowe Price Associates first reported a position in Howard Bancorp, Inc. Common Stock in Q2 2015 and held it in 27 quarters.
  • T. Rowe Price Associates's Howard Bancorp, Inc. Common Stock position peaked at $41.2M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Howard Bancorp, Inc. Common Stock as of Q1 2022.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.